Literature DB >> 6365780

Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide.

R D Nelson, M J Herron, R T McCormack, R C Gehrz.   

Abstract

The literature on chronic mucocutaneous candidiasis contains multiple reports which suggest that loss of cell-mediated immunity in this disease may be related in part to the presence of an inhibitory factor(s) present in patient plasma. One such inhibitory factor has been suggested to be mannan polysaccharide released from the cell wall of the pathogen. The present report describes results of experiments to consider mechanisms by which yeast mannan influences proliferative responses of human lymphocytes. Mannan for these experiments was isolated from Saccharomyces cerevisiae. We observed that mannan-mediated inhibition of proliferative responses to a battery of stimuli (phytohemagglutinin, pokeweed mitogen, and Candida, mumps, streptococcus, cytomegalovirus, and herpes simplex virus antigens) was related in part to an effect of copper associated with the mannan and possibly to the superoxide dismutase activity of the mannan-copper complex. Mannan made deficient in copper by use of a copper-chelating resin appeared to inhibit only lymphoproliferation stimulated by the Candida antigen. These results suggest that inhibitory effects of yeast mannans on lymphoproliferative responses may involve at least two mechanisms, one related to hydrogen peroxide production augmented by mannan-copper complexes and another related to still unknown effects independent of the metal ligand. We propose that our results represent a significant novel observation which may be useful in understanding mechanisms of immunoinhibitory effects of C. albicans mannan.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365780      PMCID: PMC264290          DOI: 10.1128/iai.43.3.1041-1046.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Immune abnormalities associated with chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; J M Higgs; R S Wells; M Yamamura; J R Hobbs; P J Holt
Journal:  Cell Immunol       Date:  1973-03       Impact factor: 4.868

3.  A study on purified apo-erythrocuprein.

Authors:  U Weser; G Barth; C Djerassi; H J Hartmann; P Krauss; G Voelcker; W Voelter; W Voetsch
Journal:  Biochim Biophys Acta       Date:  1972-08-31

4.  Cytomegalovirus vaccine. Specific humoral and cellular immune responses in human volunteers.

Authors:  R C Gehrz; W R Christianson; K M Linner; K E Groth; H H Balfour
Journal:  Arch Intern Med       Date:  1980-07

5.  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

6.  Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; P S Shirley; R B Johnston
Journal:  Blood       Date:  1976-04       Impact factor: 22.113

7.  Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.

Authors:  R D Deshazo; C Ewel; S Londono; Z Metzger; J T Hoffeld; J J Oppenheim
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

8.  Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.

Authors:  A Fischer; J J Ballet; C Griscelli
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

9.  Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.

Authors:  Z Metzger; J T Hoffeld; J J Oppenheim
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture.

Authors:  E Pick; Y Keisari
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

View more
  7 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages.

Authors:  T Chinen; M H Qureshi; Y Koguchi; K Kawakami
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 3.  Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

Authors:  R D Nelson; N Shibata; R P Podzorski; M J Herron
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Induction of natural killer cell activity by inactivated Candida albicans in mice.

Authors:  P Marconi; L Scaringi; L Tissi; M Boccanera; F Bistoni; E Bonmassar; A Cassone
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues.

Authors:  N Shibata; M Arai; E Haga; T Kikuchi; M Najima; T Satoh; H Kobayashi; S Suzuki
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein.

Authors:  E W Carrow; J E Domer
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

7.  Structure of cell wall mannan of Candida kefyr IFO 0586.

Authors:  H Kobayashi; M Komido; M Watanabe; K Matsuda; M Suzuki; T Ikeda; H Oyamada; N Shibata; S Suzuki
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.